Abstract:Background/aims Decompensated cirrhosis is characterized by an imbalance in the innate immune system, leading to low-grade systemic inflammation. Inflammatory cytokines secreted by monocytes and macrophages have been implicated in the pathogenesis of portal hypertension and its complications. Trans- jugular intrahepatic portosystemic shunt (TIPS) is currently used for the treatment of complications of portal hypertension, but whether portosystemic derivation results in changes in the biology of inflammatory cell is currently unknown. Here we investigated the levels of different soluble factors in peripheral blood monocytes and plasma collected from different vascular districts, in a group of patients undergoing TIPS for a complication of cirrhosis. Method Fifteen patients with complications of portal hypertension referred to our Unit for TIPS placement were enrolled. During the TIPS procedure, blood from the portal (PV) and jugular veins (JV) was drawn, and at 4 weeks post-TIPS placement a sample from a peripheral vein was repeated. Monocytes were isolated from peripheral blood mononuclear cells by adherence to plastic after Ficoll-Hypaque purification and stimulated with LPS (1 µg/ml) for 8 and 24 hours. Gene expression was evaluated by Real-Time PCR. In a subset of patients, quantitative analysis of cytokines in plasma and conditioned medium of monocytes was performed using multiplex assay. Pro-angiogenic effects were evaluated by HUVEC cell migration assay and endothelial tube formation assay. Results In unstimulated conditions, gene expression of interlukin-1beta, interleukin-6 and interleukin-10 was significantly higher in monocytes collected from the PV that in those from either the JV pre-TIPS or the peripheral vein post-TIPS. In addition, LPS-mediated increase in mRNA for these cytokines was higher in monocytes collected in the PV. Similar changes were found when plasma- or monocyte-secreted cytokines at the protein level were analyzed in a subset of patients. These modifications were not a general feature of monocytes isolated from the PV, because basal and stimulated expression of interlukin-8, another cytokine, did not change comparing the different vascular districts. Release of vascular-endothelial growth factor (VEGF) by monocytes and in plasma was significant lower in the peripheral vein after TIPS than in portal vein pre-TIPS. Conditioned medium from monocytes collected in different districts was used in angiogenic assays. Medium from PV monocytes was significantly more effective in inducing endothelial cell migration or vascular tube formation, two indicators of angiogenesis. Conclusion In cirrhotic patients, monocyte expression of different cytokines involved in the regulation of the inflammatory response is in general higher in the portal circulation and tends to change after reduction of portal pressure by TIPS placement. Expression of VEGF is increased in the portal circulation and is associated with an increased proangiogenic effect in vitro.

Clinical efficacy and the changes of blood NO, IL-6 and MDA in TIPS

Analyses on Clinical Efficacy of TIPS in the Treatment of Cirrhotic Portal Hypertension and Relevant Influencing Factors

Effect of transjugular intrahepatic portosystemic shunt on liver and renal functions of cirrhosis patients:report of 86 cases

Effect of TIPS on the treatment of elderly patients with cirrhotic portal hypertension and hemody-namics

Safety and clinical efficacy of three types stents of transjugular intrahepatic porto-systemic shunt in treatment of cirrhosis with portal hypertension

Clinical Study on Transjugular Intrahepatic Portosystemic Shunt in Treatment of Portal Hypertension of Patients with Hepatocellular Carcinoma

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China:A national survey analysis

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis

Dynamic Changes in Liver Function after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis

Efficacy of transjugular intrahepatic portosystemic shunts in treating cirrhotic esophageal-gastric variceal bleeding

Survey of 15 Liver Cirrhosis Patients Without Upper Gastrointestinal Hemorrhage after Transjugular Intrahepatic Portosystemic Shunt

Long-term Clinical Outcomes in Patients with Viral Hepatitis Related Liver Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Treatment

The Treatment of Liver Cirrhosis Complicated with Portal Hypertension by Transjugalar Intrahepatic Portosystemic Shunt (a Follow-up Study of 126 Cases)

Efficacy of Transjugular Intrahepatic Portosystemic Shunt with Covered Stents in the Treatment of Portal Hypertension in 46 Patients with Primary Hepatocellular Carcinoma

[Hemodynamic Response in Cirrhotic Patients with Transjugular Intrahepatic Portosystemic Shunt].

Effect of transjugular intrahepatic portosystemic shunt in treatment of chronic portal vein thrombosis with esophageal variceal bleeding

Clinical effect of single covered stent and double covered stent on TIPS in the treatment of hemorrhage due to rupture of esophageal and gastric varices in cirrhosis and its influence on immune function

Placement of a trans-jugular intrahepatic portosystemic shunt (TIPS) modifies the expression of soluble mediators by circulating monocytes

Role of transjugular intrahepatic portosystemic shunt in the control of variceal bleeding and ascites due to portal hypertension

Effects of Transjugular Intrahepatic Portosystemic Shunt Combined with Left Gastric Vein Embolization on the Liver Function of Patients with Liver Cirrhosis

[Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases]